Methods of utilizing baseline values for indirect response models

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 36, Issue 5, 2009, Pages 381-405

  Woo, Sukyung ^a,b   Pawaskar, Dipti ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Baseline responses; Indirect response models; Modeling and simulation; Pharmacodynamics; Turnover models

Indexed keywords

ACCURACY; ANALYTICAL ERROR; ARTICLE; CONTROLLED STUDY; HUMAN; IC 50; INDIRECT RESPONSE MODEL; MATHEMATICAL COMPUTING; MEDICAL LITERATURE; MODEL; NONRESPONSE BIAS; PHARMACODYNAMICS; PRIORITY JOURNAL; TASK PERFORMANCE;

ALGORITHMS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, STATISTICAL; PHARMACOKINETICS; PHARMACOLOGY; SOFTWARE;

EID: 70350573962     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10928-009-9128-6     Document Type: Article

References (15)

1. F Schindel 2000 Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study Eur J Clin Pharmacol 56 685 688 10.1007/s002280000230 1:CAS:528:DC%2BD3MXlt1Knug%3D%3D 11214776 (Pubitemid 32204489)
2. Colburn WA, Gibson DM (1988) Endogenous agonists and pharmacokinetic/ pharmacodynamic modeling of baseline effects in current problems, potential solutions. In: Kroboth PD, Smith RB, Juhl RP (eds) Pharmacokinetics and pharmacodynamics, vol 2. Harvey Whitney Books, Cincinnati
3. C Dansirikul HE Silber MO Karlsson 2008 Approaches to handling pharmacodynamic baseline responses J Pharmacokinet Pharmacodyn 35 269 283 10.1007/s10928-008-9088-2 1:CAS:528:DC%2BD1cXosVGiu74%3D 18446428
4. YN Sun WJ Jusko 1999 Role of baseline parameters in determining indirect pharmacodynamic responses J Pharm Sci 88 987 990 10.1021/js9901155 1:CAS:528:DyaK1MXlslOmt70%3D 10514344 (Pubitemid 29480588)
5. D'Argenio DZ, Schumitzky A (1997) ADAPT II user's guide: pharmacokinetic/pharmacodynamic system analysis software. Biomedical Simulations Resource, Los Angeles, CA
6. LB Sheiner SL Beal 1981 Some suggestions for measuring predictive performance J Pharmacokinet Biopharm 9 503 512 10.1007/BF01060893 1:STN:280:DyaL38%2FnslGruw%3D%3D 7310648
7. NL Dayneka V Garg WJ Jusko 1993 Comparison of four basic models of indirect pharmacodynamic responses J Pharmacokinet Biopharm 21 457 478 10.1007/BF01061691 1:CAS:528:DyaK2cXitlGhsb0%3D 8133465 (Pubitemid 24025269)
8. Z Yao W Krzyzanski WJ Jusko 2006 Assessment of basic indirect pharmacodynamic response models with physiological limits J Pharmacokinet Pharmacodyn 33 167 193 10.1007/s10928-006-9003-7 16547797
9. P Gozzi I Pahlman L Palmer A Gronberg S Persson 1999 Pharmacokinetic- pharmacodynamic modeling of the immunomodulating agent susalimod and experimentally induced tumor necrosis factor-alpha levels in the mouse J Pharmacol Exp Ther 291 199 203 1:CAS:528:DyaK1MXmtlaksL8%3D 10490905
10. TM Post JI Freijer J DeJongh M Danhof 2005 Disease system analysis: basic disease progression models in degenerative disease Pharm Res 22 1038 1049 10.1007/s11095-005-5641-5 1:CAS:528:DC%2BD2MXmt1yntb8%3D 16028004 (Pubitemid 41127061)
11. W Krzyzanski A Chakraborty WJ Jusko 2000 Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models Chronobiol Int 17 77 93 10.1081/CBI-100101034 1:CAS:528: DC%2BD3cXhtFOlsrs%3D 10672436 (Pubitemid 30078523)
12. A Chakraborty W Krzyzanski WJ Jusko 1999 Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods J Pharmacokinet Biopharm 27 23 43 10.1023/A:1020678628317 1:CAS:528:DyaK1MXlvVOmtLc%3D 10533696 (Pubitemid 29382286)
13. M Ramanathan 2002 A dispersion model for cellular signal transduction cascades Pharm Res 19 1544 1548 10.1023/A:1020421119533 1:CAS:528: DC%2BD38XnsFSgtro%3D 12425474 (Pubitemid 35266561)
14. W Krzyzanski J Dmochowski N Matsushima WJ Jusko 2006 Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models J Pharmacokinet Pharmacodyn 33 635 655 10.1007/s10928-006-9028-y 16941234 (Pubitemid 44386861)
15. JE Ahn MO Karlsson A Dunne TM Ludden 2008 Likelihood based approaches to handling data below the quantification limit using NONMEM VI J Pharmacokinet Pharmacodyn 35 401 421 10.1007/s10928-008-9094-4 18686017